HUMAN LIVER DEHYDROEPIANDROSTERONE SULFOTRANSFERASE - NATURE AND EXTENT OF INDIVIDUAL VARIATION

被引:55
作者
AKSOY, IA
SOCHOROVA, V
WEINSHILBOUM, RM
机构
[1] MAYO CLIN & MAYO FDN, DEPT PHARMACOL, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO GRAD SCH MED, ROCHESTER, MN 55901 USA
关键词
D O I
10.1038/clpt.1993.181
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dehydroepiandrosterone sulfotransferase (DHEA ST) catalyzes the sulfation of steroid hormones such as DHEA, estrone, and estradiol. As a first step in pharmacogenetic studies of DHEA ST in humans, we measured individual variation in DHEA ST enzymatic activity and thermal stability in 94 samples of human hepatic tissue, 39 of which were from patients with normal liver function studies. Neither level of enzyme activity nor thermal stability were significantly correlated with either time of tissue storage at -80-degrees-C or patient age. In addition, there were no gender-dependent differences in DHEA ST activity in these samples. DHEA ST enzymatic activity varied 4.6-fold, with a mean value of 317 +/- 100 units/gm tissue (mean +/- SD) in all samples and 318 +/- 104 units/gm in the subset of 39 samples from patients with normal hepatic function studies. Frequency distribution of DHEA ST activity for both the entire group of 94 samples and the subset of 39 were bimodal, with 25% and 21% included in a high activity subgroup, respectively. The presence of this high activity subgroup was confirmed when data for samples from male and female patients were evaluated separately and when only data for white patients were examined. The existence of a subgroup of subjects with a high level of DHEA ST enzymatic activity in liver and a 4.6-fold range in this activity have implications for individual differences in the sulfate conjugation of endogenous and exogenously administered steroid hormones and raise the possibility of pharmacogenetic regulation of this important enzyme in humans.
引用
收藏
页码:498 / 506
页数:9
相关论文
共 34 条
  • [1] AKSOY IA, 1993, DRUG METAB DISPOS, V21, P268
  • [2] A PROSPECTIVE-STUDY OF DEHYDROEPIANDROSTERONE SULFATE, MORTALITY, AND CARDIOVASCULAR-DISEASE
    BARRETTCONNOR, E
    KHAW, KT
    YEN, SSC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) : 1519 - 1524
  • [3] HUMAN LIVER CATECHOL-O-METHYLTRANSFERASE PHARMACOGENETICS
    BOUDIKOVA, B
    SZUMLANSKI, C
    MAIDAK, B
    WEINSHILBOUM, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) : 381 - 389
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] HUMAN-LIVER PHENOL SULFOTRANSFERASE - ASSAY CONDITIONS, BIOCHEMICAL-PROPERTIES AND PARTIAL-PURIFICATION OF ISOZYMES OF THE THERMOSTABLE FORM
    CAMPBELL, NRC
    VANLOON, JA
    WEINSHILBOUM, RM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (09) : 1435 - 1446
  • [6] MOLECULAR ENZYMOLOGY OF HUMAN LIVER CYTOSOLIC SULFOTRANSFERASES
    FALANY, CN
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (07) : 255 - 259
  • [7] PURIFICATION AND CHARACTERIZATION OF HUMAN LIVER PHENOL-SULFATING PHENOL SULFOTRANSFERASE
    FALANY, CN
    VAZQUEZ, ME
    HEROUX, JA
    ROTH, JA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 278 (02) : 312 - 318
  • [8] PURIFICATION AND CHARACTERIZATION OF HUMAN-LIVER DEHYDROEPIANDROSTERONE SULFOTRANSFERASE
    FALANY, CN
    VAZQUEZ, ME
    KALB, JM
    [J]. BIOCHEMICAL JOURNAL, 1989, 260 (03) : 641 - 646
  • [9] RAT-BRAIN PHENOLSULFOTRANSFERASE-PARTIAL PURIFICATION AND SOME PROPERTIES
    FOLDES, A
    MEEK, JL
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 327 (02) : 365 - 374
  • [10] HERNANDEZ JS, 1992, DRUG METAB DISPOS, V20, P413